Enhancing IgG fragment crystallizable sialylation improves the therapeutic activity of IL-23 cytokine blockade.
Saved in:
| Title: | Enhancing IgG fragment crystallizable sialylation improves the therapeutic activity of IL-23 cytokine blockade. |
|---|---|
| Authors: | Kämpf S; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Hematianlarki M; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Altmann L; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Bright JM; Nuvig Therapeutics Inc., Palo Alto, California, USA., Toda AM; Nuvig Therapeutics Inc., Palo Alto, California, USA., Mirzapoor Z; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Zollner V; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Werner A; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Bulang J; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Radovani B; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Wöhner M; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany., Avery W; Nuvig Therapeutics Inc., Palo Alto, California, USA., Karbarz MJ; Nuvig Therapeutics Inc., Palo Alto, California, USA., Conley PB; Nuvig Therapeutics Inc., Palo Alto, California, USA., Coffey GP; Nuvig Therapeutics Inc., Palo Alto, California, USA., Nimmerjahn F; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany. |
| Source: | JCI insight [JCI Insight] 2026 Feb 19; Vol. 11 (7). Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: eCollection Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41712290 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Enhancing IgG fragment crystallizable sialylation improves the therapeutic activity of IL-23 cytokine blockade. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kämpf+S%22">Kämpf S</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hematianlarki+M%22">Hematianlarki M</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Altmann+L%22">Altmann L</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bright+JM%22">Bright JM</searchLink>; Nuvig Therapeutics Inc., Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Toda+AM%22">Toda AM</searchLink>; Nuvig Therapeutics Inc., Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Mirzapoor+Z%22">Mirzapoor Z</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Zollner+V%22">Zollner V</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Werner+A%22">Werner A</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Bulang+J%22">Bulang J</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Radovani+B%22">Radovani B</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Wöhner+M%22">Wöhner M</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Avery+W%22">Avery W</searchLink>; Nuvig Therapeutics Inc., Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Karbarz+MJ%22">Karbarz MJ</searchLink>; Nuvig Therapeutics Inc., Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Conley+PB%22">Conley PB</searchLink>; Nuvig Therapeutics Inc., Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Coffey+GP%22">Coffey GP</searchLink>; Nuvig Therapeutics Inc., Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22Nimmerjahn+F%22">Nimmerjahn F</searchLink>; Division of Genetics, Department of Biology, Friedrich Alexander University Erlangen-Nürnberg, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101676073%22">JCI insight</searchLink> [JCI Insight] 2026 Feb 19; Vol. 11 (7). <i>Date of Electronic Publication: </i>2026 Feb 19 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101676073 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2379-3708 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223793708%22">23793708 </searchLink><i>NLM ISO Abbreviation: </i>JCI Insight <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41712290 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/jci.insight.198630 Languages: – Code: eng Text: English Titles: – TitleFull: Enhancing IgG fragment crystallizable sialylation improves the therapeutic activity of IL-23 cytokine blockade. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kämpf S – PersonEntity: Name: NameFull: Hematianlarki M – PersonEntity: Name: NameFull: Altmann L – PersonEntity: Name: NameFull: Bright JM – PersonEntity: Name: NameFull: Toda AM – PersonEntity: Name: NameFull: Mirzapoor Z – PersonEntity: Name: NameFull: Zollner V – PersonEntity: Name: NameFull: Werner A – PersonEntity: Name: NameFull: Bulang J – PersonEntity: Name: NameFull: Radovani B – PersonEntity: Name: NameFull: Wöhner M – PersonEntity: Name: NameFull: Avery W – PersonEntity: Name: NameFull: Karbarz MJ – PersonEntity: Name: NameFull: Conley PB – PersonEntity: Name: NameFull: Coffey GP – PersonEntity: Name: NameFull: Nimmerjahn F IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 02 Text: 2026 Feb 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2379-3708 Numbering: – Type: volume Value: 11 – Type: issue Value: 7 Titles: – TitleFull: JCI insight Type: main |
| ResultId | 1 |